1. Home
  2. RVNC vs UIS Comparison

RVNC vs UIS Comparison

Compare RVNC & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • UIS
  • Stock Information
  • Founded
  • RVNC 1999
  • UIS 1942
  • Country
  • RVNC United States
  • UIS United States
  • Employees
  • RVNC N/A
  • UIS N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • UIS EDP Services
  • Sector
  • RVNC Health Care
  • UIS Technology
  • Exchange
  • RVNC Nasdaq
  • UIS Nasdaq
  • Market Cap
  • RVNC 292.5M
  • UIS 294.9M
  • IPO Year
  • RVNC 2014
  • UIS N/A
  • Fundamental
  • Price
  • RVNC $3.65
  • UIS $4.66
  • Analyst Decision
  • RVNC Buy
  • UIS
  • Analyst Count
  • RVNC 9
  • UIS 0
  • Target Price
  • RVNC $12.00
  • UIS N/A
  • AVG Volume (30 Days)
  • RVNC 2.0M
  • UIS 413.6K
  • Earning Date
  • RVNC 08-06-2024
  • UIS 07-30-2024
  • Dividend Yield
  • RVNC N/A
  • UIS N/A
  • EPS Growth
  • RVNC N/A
  • UIS N/A
  • EPS
  • RVNC N/A
  • UIS N/A
  • Revenue
  • RVNC $236,645,000.00
  • UIS $1,986,800,000.00
  • Revenue This Year
  • RVNC $20.63
  • UIS $0.77
  • Revenue Next Year
  • RVNC $34.80
  • UIS $3.15
  • P/E Ratio
  • RVNC N/A
  • UIS N/A
  • Revenue Growth
  • RVNC 54.59
  • UIS N/A
  • 52 Week Low
  • RVNC $2.30
  • UIS $2.60
  • 52 Week High
  • RVNC $24.87
  • UIS $8.12
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 60.38
  • UIS 56.96
  • Support Level
  • RVNC $2.40
  • UIS $4.21
  • Resistance Level
  • RVNC $4.38
  • UIS $4.90
  • Average True Range (ATR)
  • RVNC 0.30
  • UIS 0.16
  • MACD
  • RVNC 0.16
  • UIS 0.08
  • Stochastic Oscillator
  • RVNC 63.29
  • UIS 71.84

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides solutions that transform digital workplaces securely and create exceptional end-user experiences. CA&I provides digital platform, applications and infrastructure solutions. ECS provides solutions that harness secure, continuous high-intensity computing and enable digital services through software-defined operating environments.

Share on Social Networks: